HomeINDV • LON
add
Indivior PLC
Previous close
GBX 1,514.00
Year range
GBX 1,125.00 - GBX 1,938.00
Market cap
2.04B GBP
Avg Volume
328.08K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 293.00M | 21.07% |
Operating expense | 179.00M | 12.58% |
Net income | 54.00M | 129.51% |
Net profit margin | 18.43 | 124.37% |
Earnings per share | 0.43 | — |
EBITDA | 64.00M | 64.10% |
Effective tax rate | 12.90% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 410.00M | -54.09% |
Total assets | 1.95B | 10.46% |
Total liabilities | 1.95B | 13.74% |
Total equity | 0.00 | — |
Shares outstanding | 136.35M | — |
Price to book | ∞ | — |
Return on assets | 7.62% | — |
Return on capital | 54.21% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 54.00M | 129.51% |
Cash from operations | -281.00M | -1,461.11% |
Cash from investing | 6.00M | 400.00% |
Cash from financing | -21.00M | 25.00% |
Net change in cash | -294.00M | -525.53% |
Free cash flow | -260.50M | -192.83% |
About
Indivior is a specialty pharmaceuticals business. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. It is also listed on the NASDAQ Global Select Market. Wikipedia
Founded
Sep 26, 2014
Website
Employees
1,164